Gamma Biosciences is a life sciences tools platform created by KKR. Gamma’s mission is to build a leading player in next-generation bioprocessing for advanced therapies by acquiring or investing in high-potential businesses with outstanding technology and accelerating their growth. Gamma’s founding partners, together with the KKR team have years of experience in building and sustaining life sciences businesses in the bioprocess and cell & gene therapy segments.
Gamma focuses on investing in technically de-risked assets in under-invested and less liquid phases of their lifecycles. We look for stable downside protection with exposure to asymmetric upside vectors and opportunities to drive value through operational optimization, smart allocation of additional capital and strategic repositioning.